AKT1 and cancer: Tocotrienols reduce cancer growth by inhibiting angiogenesis [11,12]; δ-tocotrienol induced apoptosis in endothelial cells through growth factor-dependent phosphatidylinositol-3 kinase/PDK/Akt signalling [12].